Max Higgins, Consultant, Eric Jia-Sobota, Founder, Author at EverGlade Consulting

Max Higgins, Consultant

Max Higgins, Consultant
ARPA-H_Mission Office Innovative Solutions Openings (ISO)

ARPA-H Mission Office Innovative Solutions Openings (ISOs)

Leave a Comment / All Posts, ARPA-H, Life Sciences / By

Overview The Advanced Research Projects Agency for Health (ARPA-H) is dedicated to accelerating transformative health solutions by tackling some of the most pressing challenges in biomedical and healthcare innovation. As part of this mission, ARPA-H has launched Mission Office Innovative Solutions Openings (ISOs) that promote the development of health technologies that lie outside of the […]

ARPA-H Mission Office Innovative Solutions Openings (ISOs) Read More »

DARPA ERIS digital marketplace

Expedited Research Implementation Series (ERIS)

Leave a Comment / All Posts, DARPA, Emerging Technologies / By

What is the ERIS? The Expedited Research Implementation Series (ERIS) is a cutting-edge initiative launched by the Defense Advanced Research Projects Agency (DARPA) in partnership with the Applied Research Institute (ARI). ERIS serves as a digital marketplace that facilitates the submission, assessment, and acquisition of breakthrough technologies through rapid acquisition pathways. This unique initiative enables

Expedited Research Implementation Series (ERIS) Read More »

NIH resume issuing grants

NIH Admits Funding Freeze Was Illegal, Resumes Issuing Grants

Leave a Comment / All Posts, Life Sciences, NIH / By

Overview In a major development for the biomedical research community, the National Institutes of Health (NIH) has officially acknowledged that its recent funding freeze was unlawful and has announced the resumption of grant distributions. This decision follows weeks of controversy and legal challenges, during which research institutions, universities, and lawmakers criticized the abrupt halt in

NIH Admits Funding Freeze Was Illegal, Resumes Issuing Grants Read More »

ARPA-H_RAPID rare disease diagnostics

RAPID Solicitation

Leave a Comment / All Posts, ARPA-H, Life Sciences / By

RAPID_SOL_25_119_FINAL Overview The Advanced Research Projects Agency for Health (ARPA-H) recently announced the newly approved program for Rare disease AI/ML for Precision Integrated Diagnostics (RAPID). The RAPID program aims to significantly improve outcomes for people with rare diseases by reducing diagnostic delays by ≥50%, decreasing misdiagnosis rates, and expanding access to diagnostics. Beyond benefitting the treatment experience of

RAPID Solicitation Read More »

Court Blocks NIH Cap Indirect Cost Rate

Court Blocks NIH Cap on Indirect Cost Rates

Leave a Comment / All Posts, Life Sciences, NIH / By

Court Blocks NIH Cap on Indirect Cost Rates for Government Contracts In a significant development for research institutions and federal contractors, a federal judge has temporarily blocked the National Institutes of Health (NIH) from enforcing its cap on indirect cost rates. This decision comes as a result of a temporary restraining order (TRO) issued by

Court Blocks NIH Cap on Indirect Cost Rates Read More »

Safe Lithium-Ion Battery Development DOE

Safe Lithium-Ion Battery Development

Leave a Comment / All Posts, DOE, Emerging Technologies / By

Lithium Ion Battery Development Overview of the Solicitation The Department of Energy (DOE) and affiliates have released a Request for Proposals (RFP) for the development of a safe lithium-ion battery. This initiative aims to create a backup energy storage system capable of providing 2.4 MW*hrs of usable energy while ensuring a robust safety posture. The

Safe Lithium-Ion Battery Development Read More »

NIH Supplemental Guidance

Understanding the NIH Supplemental Guidance on Indirect Cost Rates

Leave a Comment / All Posts, Life Sciences, NIH / By

Overview The National Institutes of Health (NIH) has issued Supplemental Guidance to the 2024 NIH Grants Policy Statement regarding Indirect Cost Rates (NOT-OD-25-068). This update introduces a standardized 15% indirect cost rate for all applicable grants, aiming to streamline financial policies and enhance funding efficiency for research institutions. Purpose of the Guidance The primary objective

Understanding the NIH Supplemental Guidance on Indirect Cost Rates Read More »

molecular science DARPA

Unlocking the Future of Microsystems: DARPA’s MICA Program

Leave a Comment / All Posts, DARPA, Emerging Technologies / By

DARPA, Microsystems Induced CAtalysis (MICA) Program Overview of the MICA Program The Defense Advanced Research Projects Agency (DARPA) has recently announced a groundbreaking funding opportunity, titled “Microsystems Induced CAtalysis” (MICA). This Broad Agency Announcement (BAA) aims to enhance molecular science by creating advanced tools and techniques for controlling molecular catalysts using microsystems. This initiative goes

Unlocking the Future of Microsystems: DARPA’s MICA Program Read More »

antiviral therapeutics against filoviruses

New Opportunities with DRIVe: ReBooT and RePAIR Amendments

Leave a Comment / All Posts, BARDA, Life Sciences / By

Amendment 034 – DRIVe EZ BAA_ReBooT_RePAIR New Opportunities with DRIVe: ReBooT and RePAIR Amendments The Biomedical Advanced Research and Development Authority’s (BARDA) Division of Research, Innovation & Ventures (DRIVe) has announced updates to its Easy Broad Agency Announcement (EZ-BAA) with Amendment #034. This amendment reopens and revises the ReBooT (AOI #22) program and pauses the

New Opportunities with DRIVe: ReBooT and RePAIR Amendments Read More »

R&D Funding in Life Sciences: What's Ahead in Trump 2.0?

Webinar Alert: R&D Funding in Life Sciences: What’s Ahead in Trump 2.0?

Leave a Comment / All Posts / By

What to Expect in the Webinar: Federal Programs at Risk: Explore which key life sciences programs might face funding challenges in a new Trump administration. Emerging Opportunities: Learn about research areas poised to gain new momentum and potential funding in the evolving political landscape. Key Players Shaping Change: Get insights into the policymakers and influencers

Webinar Alert: R&D Funding in Life Sciences: What’s Ahead in Trump 2.0? Read More »

Leveraging AI to Enhance Business Intelligence

Leveraging AI to Enhance Business Intelligence

Leave a Comment / All Posts, DIU, Emerging Technologies / By

DOD’s New Initiative_AOI Solicitation Leveraging AI to Enhance Business Intelligence: The DoD’s New Initiative The Department of Defense (DoD) has identified a critical need to modernize business intelligence assessments to keep pace with evolving challenges in due diligence evaluations and industrial foreign influence analyses. To address this, the Defense Innovation Unit (DIU) has released an

Leveraging AI to Enhance Business Intelligence Read More »

ARPA-H_EIH health and biomedical research

Emerging Health Innovators (EHI) Initiative

Leave a Comment / All Posts, ARPA-H, Life Sciences / By

ARPA_H_SOL_25_118_EHI_Solicitation (1) Emerging Health Innovators Solicitation: An Opportunity to Revolutionize Health Innovation The Advanced Research Projects Agency for Health (ARPA-H) has issued the Emerging Health Innovators (EHI) Initiative Solicitation (ARPA-H-SOL-25-118), a groundbreaking funding opportunity aimed at empowering both early-career researchers and community innovators to advance health and biomedical research. Through the EHI Initiative, ARPA-H seeks

Emerging Health Innovators (EHI) Initiative Read More »

Scroll to Top